Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey L. Wade currently holds 307,000 shares of LEXICON PHARMACEUTICALS, INC./DE (LXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey L. Wade has been a net buyer of LXRX stock. They have purchased $60.8K and sold $0 worth of shares.
Jeffrey L. Wade's most recent insider trade was on Jul 8, 2024, when they sold 307,000 shares at $0.00 per share.
Jeffrey L. Wade serves as Executive at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have executed 78 insider transactions totaling $60.8K over their tenure at the company.
Jeffrey L. Wade holds the position of Executive at LEXICON PHARMACEUTICALS, INC./DE, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Jeffrey L. Wade has shown a buying trading pattern, with $60.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jeffrey L. Wade was on Feb 28, 2021, when they sold $191.1K worth of LXRX shares. This transaction involved 26,584 shares at $7.19 per share.
Jeffrey L. Wade currently owns 307,000 shares of LEXICON PHARMACEUTICALS, INC./DE (LXRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey L. Wade's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey L. Wade has 78 Form 4 filings on record as an insider at LEXICON PHARMACEUTICALS, INC./DE.
Set alerts for Jeffrey L. Wade and 40,000+ other insiders.